CKD STAGE 4

Clinical trials for CKD STAGE 4 explained in plain language.

Never miss a new study

Get alerted when new CKD STAGE 4 trials appear

Sign up with your email to follow new studies for CKD STAGE 4, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Can a diabetes drug protect kidneys in advanced disease?

Disease control Ongoing

This study looks at whether canagliflozin, a drug used for diabetes, can safely reduce kidney damage in people with advanced chronic kidney disease (CKD), including those on dialysis. About 35 adults with stage 4 or 5 CKD will take the drug for up to 26 weeks. Researchers will me…

Matched conditions: CKD STAGE 4

Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control

Last updated May 08, 2026 12:01 UTC

CKD STAGE 4

Get alerted when new CKD STAGE 4 trials appear

Can a diabetes drug protect kidneys in advanced disease?